Testosterone Cypionate (TRT)

Overview

The standard of care for documented hypogonadism. Weekly injectable with quarterly labs, provider reviews, and coaching wrapped in - not a cash-pay optimization clinic.

Key benefits

• 01
  Restores total T into the evidence-based 500-900 ng/dL window
• 02
  Quarterly labs: total/free T, estradiol, SHBG, CBC, PSA, ApoB
• 03
  Provider-managed titration, no cookie-cutter dosing
• 04
  Coaching on sleep, training, and protein that amplifies the signal

Clinical rationale

Testosterone cypionate is a long-acting ester with a half-life around seven days, making weekly or split-weekly dosing the norm. Eligibility requires two morning total testosterone draws under 300 ng/dL plus symptoms, with baseline PSA, CBC, estradiol, and a cardiovascular history review. Monitoring every 3-6 months tracks hematocrit, PSA, and estradiol to guide dose or adjuncts.

Fit check

Using it well

Safety notes

• Prescription products require clinical eligibility and provider approval.
• Medication availability varies by state and clinical criteria.

Questions

• How do I know I'm actually low?+

  Two separate morning total T draws under 300 ng/dL plus real symptoms. A single draw on a bad week is not a diagnosis. Our Advanced panel plus the men's workup gets you an answer.
• Is fertility off the table?+

  Exogenous TRT suppresses LH, FSH, and endogenous production - which drops sperm count. If fertility is on the table soon, we will have that conversation before starting and often choose a different protocol.
• Will I need an AI?+

  Not by default. Most members titrate dose first, then split weekly dosing, before touching an aromatase inhibitor. E2 management without data is how people crash estrogen.
• Clinic vs telehealth TRT - what's different?+

  The eligibility bar is the same. Telehealth adds the labs, messaging, and follow-up rigor that most clinic visits skip. See the compare guide for a row-by-row.